COLUMVI conc perf 2.5 mg/2.5 ml flac 2.5 ml
7680682970018
CH-68297
L01FX
07.16.1.
1 / 3
google
Details
- Product number
- 6829701
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- glofitamabum 2.5 mg, histidinum, histidini hydrochloridum monohydricum, methioninum, saccharum, polysorbatum 20, aqua ad iniectabile, q.s. ad solutionem pro 2.5 ml.
Articles (1)
Columvi 2.5 mg/2.5 ml, Konzentrat zur Herstellung einer Infusionslösung
Konzentrat
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
2.5 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Authorization holder
Roche Pharma (Schweiz) AG
4058 Basel
Authorization information
- Swissmedic authorization number
- 68297
- Drug name
- Columvi, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOINF
- ATC Code
- L01FX
- Authorization status
- B
- Dispensation category
- A
- First authorization
- 07/11/2023
- Authorization expiration date
- 07/11/2025
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- COLUMVI conc perf 2.5 mg/2.5 ml flac 2.5 ml
- Description (DE)
- COLUMVI Inf Konz 2.5 mg/2.5 ml Durchstf 2.5 ml
- Market launch
- 07/11/2023
- Narcotic (BTM)
- No